uniQure (QURE) Current Taxes (2024 - 2025)
uniQure (QURE) posted quarterly Current Taxes of $7.8 million for Q3 2025, up 2569.28% quarter-over-quarter from $293000.0 in Q4 2024.
uniQure (QURE) Current Taxes (2024 - 2025) Analysis & Trends
uniQure's Current Taxes history runs 2 years deep, the most recent figure standing at $7.8 million for Q3 2025.
- In Q3 2025, Current Taxes changed N/A year-over-year to $7.8 million; the TTM figure through Sep 2025 stood at $7.8 million (changed N/A YoY), while the FY2024 annual figure was $293000.0, changed N/A from the prior year.
- Current Taxes for Q3 2025 stood at $7.8 million, up from $293000.0 in the prior quarter.
- The five-year high for Current Taxes was $7.8 million in Q3 2025, with the low at $293000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.82 Mn |
| Dec 31, 2024 | 293,000.00 |